Intarcia Therapeutics, Inc.
Boston, Massachusetts, United States
Purpose
to develop a HIV pre-exposure prophylaxis technology for use in the developing world in order to further reduce the incidence rate of HIV infections
Division
Global Health
Date
May 2017
Region Served
AFRICA
Committed amount
$9,407,063
Grant topic
HIV
Duration (months)
38
Grantee location
Boston, Massachusetts, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.